Specimen: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. Recommended specimen for patient on UDCA treatment: Before morning dose.

Stability (Room): 6 hrs

Stability (Refrigerated): 1 week

Stability (Frozen): 3 months

Method: Enzymatic Colorimetric

Comment: For patients treated with UDCA, LC-MS/MS is the recommended method for monitoring response to therapy.

Price: Contact Medilab

Turnaround time (TAT): 5 – 15 days

Usage: Total bile acids are metabolized in the liver and can serve as a marker for normal liver function. Increases in serum bile acids are seen in patients with acute hepatitis, chronic hepatitis, liver sclerosis, liver cancer, and intrahepatic cholestasis of pregnancy. In Obstetric Cholestasis, concentrations greater than 15 μmol/L usually confirms the diagnosis in the absence of other hepatic disease. Bile acid concentrations greater than 40 μmol/L have been associated with increased fetal risk.

Specialty: Gynecologist, Physician

Disease: Disorders of Liver

Components:

Courier Charges:

Home Collection: Available

Department:

Pre-test Information: Overnight fasting is preferred. Recommended specimen for patient on UDCA treatment: Before morning dose